30.07.2013 • NewsBASFClariantQ2 2013

Clariant Profit Rises as Restructuring Bears Fruit

Swiss speciality chemicals maker Clariant posted a better than expected second-quarter profit as it reaped gains from a restructuring and said it was slowly moving towards its short and mid-term targets.

Net profit rose to 79 million Swiss francs ($84.8 million) from 68 million francs a year earlier on the back of 1.54 billion in revenues, up 2% in local currencies.

Analysts on average had forecast net profit of 68.3 million francs and sales of 1.55 billion francs in a Reuters poll.

The company sold three of its lower margin cyclical units late last year and reorganized itself into four business units - care chemicals, plastics and coatings, natural resources and catalysis and energy.

Chief Executive Hariolf Kottmann said the shine was coming off emerging markets, but that the company continued to see a fairly stable economic environment, albeit at a low level.

Last week, Germany's BASF called its 2013 profit goal into question as shrinking European markets and slower growth in China weighed on its second-quarter profit.

Clariant confirmed its 2015 guidance for a pretax core profit margin before exceptional items of above 17% and a return on invested capital above the peer group average.

Last month, Clariant said products currently under development could net sales of over 1 billion Swiss francs by 2017.

 

CHEManager Spotlight

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics
Creating Interfaces

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics

CHEManager Spotlight is an exclusive event tailored for practitioners and decision-makers in the chemical industry. This part of our event series delves into the latest trends and innovations in logistics to streamline your operations and drive efficiency.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.